Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP461217.RAGkGf1AoLcYQO9KL0jdo_d8diwCAo_lA9VdwK4Z9KGuo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP461217.RAGkGf1AoLcYQO9KL0jdo_d8diwCAo_lA9VdwK4Z9KGuo130_assertion type Assertion NP461217.RAGkGf1AoLcYQO9KL0jdo_d8diwCAo_lA9VdwK4Z9KGuo130_head.
- NP461217.RAGkGf1AoLcYQO9KL0jdo_d8diwCAo_lA9VdwK4Z9KGuo130_assertion description "[These butyrylcholinesterase activities do not behave as independent risk factors for metabolic syndrome, but can be considered as secondary markers for this syndrome in obese individuals with the CHE2 C5- phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461217.RAGkGf1AoLcYQO9KL0jdo_d8diwCAo_lA9VdwK4Z9KGuo130_provenance.
- NP461217.RAGkGf1AoLcYQO9KL0jdo_d8diwCAo_lA9VdwK4Z9KGuo130_assertion evidence source_evidence_literature NP461217.RAGkGf1AoLcYQO9KL0jdo_d8diwCAo_lA9VdwK4Z9KGuo130_provenance.
- NP461217.RAGkGf1AoLcYQO9KL0jdo_d8diwCAo_lA9VdwK4Z9KGuo130_assertion SIO_000772 15843232 NP461217.RAGkGf1AoLcYQO9KL0jdo_d8diwCAo_lA9VdwK4Z9KGuo130_provenance.
- NP461217.RAGkGf1AoLcYQO9KL0jdo_d8diwCAo_lA9VdwK4Z9KGuo130_assertion wasDerivedFrom befree-20140225 NP461217.RAGkGf1AoLcYQO9KL0jdo_d8diwCAo_lA9VdwK4Z9KGuo130_provenance.
- NP461217.RAGkGf1AoLcYQO9KL0jdo_d8diwCAo_lA9VdwK4Z9KGuo130_assertion wasGeneratedBy ECO_0000203 NP461217.RAGkGf1AoLcYQO9KL0jdo_d8diwCAo_lA9VdwK4Z9KGuo130_provenance.